Betta Pharmaceuticals (300558.SZ) appoints LI MAO as Chief Research and Development Officer and Chief Medical Officer.

Betta Pharmaceuticals (300558.SZ) announced that, due to the needs of the company's management, nominated by the chairman and approved by the second meeting of the Nomination Committee of the Fourth Board of Directors, the board agreed to appoint LI MAO as the Chief Research and Development Officer and Chief Medical Officer of the company. LI MAO will be in charge of the company's new drug research and medical clinical research departments, with a term from the date of board approval to the end of this term of the board of directors.